These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17341527)

  • 1. Linezolid resistance in three isolates of coagulase-negative staphylococci.
    Cieloszyk K; Amodio-Groton M; Saeed M; Coyle CM
    Ann Pharmacother; 2007 Mar; 41(3):526-7. PubMed ID: 17341527
    [No Abstract]   [Full Text] [Related]  

  • 2. Linezolid therapy of bloodborne teicoplanin-resistant Staphylococcus haemolyticus.
    Mohammedi I; Malhière S; Robert D; Charveriat MA; Etienne J
    Infection; 2006 Oct; 34(5):292-3. PubMed ID: 17033757
    [No Abstract]   [Full Text] [Related]  

  • 3. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci.
    Potoski BA; Adams J; Clarke L; Shutt K; Linden PK; Baxter C; Pasculle AW; Capitano B; Peleg AY; Szabo D; Paterson DL
    Clin Infect Dis; 2006 Jul; 43(2):165-71. PubMed ID: 16779742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia due to a linezolid "tolerant" strain.
    Cunha BA; Nausheen S; Schoch P
    Heart Lung; 2010; 39(2):173-5. PubMed ID: 20207279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
    Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
    Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
    [No Abstract]   [Full Text] [Related]  

  • 7. Sepsis due to linezolid resistant Staphylococcus cohnii and Staphylococcus kloosii: first reports of linezolid resistance in coagulase negative staphylococci from India.
    Peer MA; Nasir RA; Kakru DK; Fomda BA; Bashir G; Sheikh IA
    Indian J Med Microbiol; 2011; 29(1):60-2. PubMed ID: 21304198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection by two linezolid-resistant coagulase-negative staphylococci with two different resistance determinants.
    Mazzariol A; Kocsis E; Bragagnolo L; Pellizzer G; Rassu M; Cornaglia G
    Scand J Infect Dis; 2012 Dec; 44(12):978-81. PubMed ID: 22830638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci.
    Dandache P; Moise PA; Orsini J; Montecalvo M; Sakoulas G
    J Antimicrob Chemother; 2009 Nov; 64(5):1114-5. PubMed ID: 19734169
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.
    Balkhair A; Al Muharrmi Z; Darwish L; Farhan H; Sallam M
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e227-9. PubMed ID: 20005763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.
    Kosowska-Shick K; Julian KG; McGhee PL; Appelbaum PC; Whitener CJ
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):34-9. PubMed ID: 20727467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Gascun C; Rajan L; O'Neill E; Smyth EG
    J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 15. Nosocomial spread of linezolid-resistant Staphylococcus haemolyticus infections in an intensive care unit.
    Rodríguez-Aranda A; Daskalaki M; Villar J; Sanz F; Otero JR; Chaves F
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):398-402. PubMed ID: 19232856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine antimicrobial susceptibility testing of coagulase-negative staphylococci isolated from blood cultures: is it necessary?
    Chandran AU; Rennie R
    Clin Microbiol Infect; 2005 Dec; 11(12):1037-40. PubMed ID: 16307561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization.
    Mulanovich VE; Huband MD; McCurdy SP; Lemmon MM; Lescoe M; Jiang Y; Rolston KV; LaSala PR
    J Antimicrob Chemother; 2010 Sep; 65(9):2001-4. PubMed ID: 20581120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Beeck VO; Dhif N; Philipp J; De Bels D
    J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
    [No Abstract]   [Full Text] [Related]  

  • 19. Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene.
    Lincopan N; de Almeida LM; Elmor de Araújo MR; Mamizuka EM
    Int J Antimicrob Agents; 2009 Sep; 34(3):281-2. PubMed ID: 19376688
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
    Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
    Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.